Could a belly pain pump replace narcotics after hysterectomy?

NCT ID NCT04130464

Recruiting now Symptom relief Sponsor: Ying Liu Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a continuous pump delivering numbing medicine into the belly can reduce pain and the need for narcotics after minimally invasive hysterectomy. About 120 women having surgery for non-cancer reasons will be randomly assigned to receive either a numbing drug, a numbing drug plus an anti-inflammatory, or a placebo for 72 hours after surgery. Researchers will measure pain levels and total painkiller use over three days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ropivacaine and ketorolac
What this could lead to: If it works, this could offer a better way to manage pain after hysterectomy and reduce the need for strong narcotics.
What could go wrong: This is a Phase 4 trial with 120 participants, so results may not apply to everyone. The pain pump itself could cause discomfort or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GYNECOLOGIC SURGICAL PROCEDURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GYNECOLOGIC SURGICAL PROCEDURES HYSTERECTOMY NARCOTIC USE PAIN, POSTOPERATIVE

Contacts and locations

Locations

MedStar Washington Hospital Center
RECRUITING

Washington D.C., District of Columbia, 20010, United States
The GW Medical Faculty Associates
RECRUITING

Washington D.C., District of Columbia, 20037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.